Strong H1 2026 results featured 0.7% organic sales growth, a 15.4% EBITDA margin, and robust free cash flow. Strategic M&A and portfolio rotation accelerated, with high-growth markets and construction chemicals driving outperformance. Guidance remains positive for H2.

Based on

This is an AI-generated summary and may contain inaccuracies. Please verify any important information with the original source.